FAM200B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.841800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.002000E-01
Normal-vs-Stage2
5.936600E-01
Normal-vs-Stage3
1.848610E-01
Normal-vs-Stage4
8.257800E-01
Stage1-vs-Stage2
2.119900E-02
Stage1-vs-Stage3
7.155600E-02
Stage1-vs-Stage4
2.812400E-01
Stage2-vs-Stage3
4.086600E-01
Stage2-vs-Stage4
6.927200E-01
Stage3-vs-Stage4
2.525800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.178000E-01
Normal-vs-AfricanAmerican
8.292000E-01
Normal-vs-Asian
4.119400E-01
Caucasian-vs-AfricanAmerican
9.213000E-01
Caucasian-vs-Asian
2.474800E-01
AfricanAmerican-vs-Asian
5.869200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.214600E-01
Normal-vs-Female
9.712200E-01
Male-vs-Female
4.493600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.455800E-01
Normal-vs-Age(41-60Yrs)
7.654200E-01
Normal-vs-Age(61-80Yrs)
6.951000E-01
Normal-vs-Age(81-100Yrs)
2.271400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.128600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.251400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.933900E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.437780E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.337600E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.827000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.375600E-01
Normal-vs-Daily Drinker
9.803600E-01
Normal-vs-Weekly Drinker
4.394200E-01
Normal-vs-Occasional Drinker
8.871000E-01
Normal-vs-Social Drinker
8.028400E-01
Non Drinker-vs-Daily Drinker
2.826400E-01
Non Drinker-vs-Weekly Drinker
9.071600E-01
Non Drinker-vs-Occasional Drinker
9.350300E-02
Non Drinker-vs-Social Drinker
1.915550E-01
Daily Drinker-vs-Weekly Drinker
3.757000E-01
Daily Drinker-vs-Occasional Drinker
7.867200E-01
Daily Drinker-vs-Social Drinker
5.886000E-01
Weekly Drinker-vs-Occasional Drinker
1.611650E-01
Weekly Drinker-vs-Social Drinker
2.044400E-01
Occasional Drinker-vs-Social Drinker
7.349200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.928600E-01
Normal-vs-Grade 2
8.754000E-01
Normal-vs-Grade 3
8.583800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.570400E-02
Grade 1-vs-Grade 3
5.468400E-02
Grade 1-vs-Grade 4
7.928600E-01
Grade 2-vs-Grade 3
6.495200E-01
Grade 2-vs-Grade 4
8.754000E-01
Grade 3-vs-Grade 4
8.583800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.575640E-01
Normal-vs-NonDiabetic
9.786200E-01
Diabetic-vs-NonDiabetic
1.516920E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.519000E-01
Normal-vs-NoPancreatitis
8.303600E-01
Pancreatitis-vs-NoPancreatitis
9.818000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.598600E-01
Normal-vs-N1
6.555200E-01
N0-vs-N1
1.172430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.101600E-01
Normal-vs-TP53-NonMutant
5.296800E-01
TP53-Mutant-vs-TP53-NonMutant
2.530400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
